Hiroshi Saijo

Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy

Yuki Kagoya, Tingxi Guo, Brian Yeung et al. · Cancer Immunology Research · 2020 · 167 citations

Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition

Yosuke Shionoya, Takayuki Kanaseki, Sho Miyamoto et al. · OncoImmunology · 2017 · 63 citations · Full text

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy

Takuya Asano, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Oncotarget · 2016 · 47 citations · Full text

Pathology, Cervical Cancer Stemness, Subfamily 6 +16

Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer

Tasuku Mariya, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Oncotarget · 2016 · 44 citations · Full text

Platinum Resistance, Health Sciences, Chemotherapy-resistant Ovarian Cancer +15

Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells

Yuki Kagoya, Hiroshi Saijo, Yukiko Matsunaga et al. · Journal of Autoimmunity · 2018 · 44 citations

Suppressive Function, Epigenetic Change, T-regulatory Cell +11